Ken Shum
Background and experience
Ken leads ZS’s China business, advising pharma, biotech and medtech clients on market strategy, access, pricing and commercial excellence. Ken has focused on the Chinese healthcare market for 10 years and oversees more than 50 projects annually, covering all stages of product life cycle and therapy areas.
His primary areas include opportunity assessments and forecasting for pipeline assets, market access and pricing for pre-launch pricing and preparation for reimbursement, go-to-market strategy and organization design, field force strategy, resourcing and implementation and commercial effectiveness.
Ken has worked in the healthcare industry for 17 years, including six years at ZS London and the past 11 years in China. Previously, Ken worked at an investment bank, focusing on mergers and acquisitions and financing for biotech and medical technology companies.
Education
M.A. in pharmacology, University of Cambridge
MBA, London Business School